Article
ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Apr 2026
Hou Jing, Xiong Yujia, Yang Yanjin, Pan Xiuyi, Qian Jingyu, Guo Xiaoyu, Zhong Jinjing, Zheng Linmao, Yin Xiaoxue, Yu Ting, Chen Xueqin, Nie Ling, Zhou Qiao, Chen Ni
Abstract excerpt
ELOC-mutated renal cell carcinoma (RCC) is a recently recognized, molecularly defined entity incorporated into the 2022 World Health Organization classification of genitourinary tumors. Approximately 50 cases of ELOC-mutated RCC have been reported, and the clinicopathologic and molecular features of this rare tumor require further clarification. Herein, we reported the pathologic and molecular characteristics of...
Topics
- Humans
- Male
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Middle Aged
- Immunohistochemistry
- Adult
- Mutation
- Female
- Biomarkers, Tumor
- Aged
- DNA Mutational Analysis
- Racemases and Epimerases